UNITED THERAPEUTICS Corp - Common Stock (UTHR)

CUSIP: 91307C102

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock
Shares outstanding
42,833,193
Total 13F shares
44,441,020
Share change
+292,845
Total reported value
$13,691,236,526
Put/Call ratio
99%
Price per share
$308.27
Number of holders
661
Value change
+$58,445,640
Number of buys
333
Number of sells
303

Quarterly Holders Quick Answers

What is CUSIP 91307C102?
CUSIP 91307C102 identifies UTHR - UNITED THERAPEUTICS Corp - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of UTHR - UNITED THERAPEUTICS Corp - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock, Inc.
13F
Company
13%
5,358,332
$1,890,633,981 31 Dec 2024
13F
VANGUARD GROUP INC
13F
Company
10%
4,441,823
$1,567,252,827 31 Dec 2024
13F
Avoro Capital Advisors LLC
13F
Company
6.4%
2,760,300
$973,944,252 31 Dec 2024
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
5.8%
2,463,891
$869,359,301 31 Dec 2024
13F
STATE STREET CORP
13F 13D/G
Company · STATE STREET CORPORATION
4.9%
from 13D/G
2,199,994
$776,298,683 31 Dec 2024
RENAISSANCE TECHNOLOGIES LLC
13F
Company
4.9%
2,089,392
$737,221,073 31 Dec 2024
13F
FMR LLC
13F
Company
3.4%
1,471,405
$519,170,317 31 Dec 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2.7%
1,138,292
$401,183,569 31 Dec 2024
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
2.3%
975,444
$344,175,661 31 Dec 2024
13F
LSV ASSET MANAGEMENT
13F
Company
2.1%
908,724
$320,634,000 31 Dec 2024
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
1.7%
709,043
$250,178,732 31 Dec 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
1.4%
620,566
$218,978,990 31 Dec 2024
13F
Pacer Advisors, Inc.
13F
Company
1.4%
597,634
$210,869,181 31 Dec 2024
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
1.3%
542,445
$191,396,294 31 Dec 2024
13F
FULLER & THALER ASSET MANAGEMENT, INC.
13F
Company
1.2%
532,914
$188,033,230 31 Dec 2024
13F
NORTHERN TRUST CORP
13F
Company
1.1%
488,854
$172,487,246 31 Dec 2024
13F
JANUS HENDERSON GROUP PLC
13F
Company
1.1%
468,996
$165,489,571 31 Dec 2024
13F
NORGES BANK
13F
Company
1%
430,122
$151,764,246 31 Dec 2024
13F
ASSETMARK, INC
13F
Company
1%
429,160
$151,424,814 31 Dec 2024
13F
MORGAN STANLEY
13F
Company
0.96%
411,752
$145,282,739 31 Dec 2024
13F
Bank of New York Mellon Corp
13F
Company
0.93%
399,424
$140,932,711 31 Dec 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.93%
397,882
$140,390,000 31 Dec 2024
13F
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC
13F
Individual
0.91%
390,093
$137,640,417 31 Dec 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.87%
370,540
$130,741,334 31 Dec 2024
13F
Swedbank AB
13F
Company
0.78%
335,505
$118,379,584 31 Dec 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.77%
331,675
$117,028,207 31 Dec 2024
13F
FRANKLIN RESOURCES INC
13F
Company
0.77%
329,379
$116,218,085 31 Dec 2024
13F
Invesco Ltd.
13F
Company
0.74%
318,451
$112,362,252 31 Dec 2024
13F
FIRST TRUST ADVISORS LP
13F
Company
0.71%
304,185
$107,328,529 31 Dec 2024
13F
FRONTIER CAPITAL MANAGEMENT CO LLC
13F
Company
0.57%
243,681
$85,980,393 31 Dec 2024
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.54%
232,373
$81,990,488 31 Dec 2024
13F
Epoch Investment Partners, Inc.
13F
Company
0.53%
226,212
$79,816,642 31 Dec 2024
13F
LORD, ABBETT & CO. LLC
13F
Company
0.51%
216,651
$76,443,000 31 Dec 2024
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.49%
209,204
$73,815,539 31 Dec 2024
13F
HSBC HOLDINGS PLC
13F
Company
0.48%
204,893
$72,358,272 31 Dec 2024
13F
THRIVENT FINANCIAL FOR LUTHERANS
13F
Company
0.48%
204,299
$72,085,000 31 Dec 2024
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.45%
193,408
$68,242,078 31 Dec 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.45%
192,256
$67,835,609 31 Dec 2024
13F
Robeco Institutional Asset Management B.V.
13F
Company
0.45%
191,925
$67,718,817 31 Dec 2024
13F
AustralianSuper Pty Ltd
13F
Company
0.44%
189,780
$66,961,975 31 Dec 2024
13F
Clark Capital Management Group, Inc.
13F
Company
0.44%
189,341
$66,807,078 31 Dec 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.42%
179,077
$63,185,529 31 Dec 2024
13F
COMERICA BANK
13F
Company
0.41%
174,647
$61,622,648 31 Dec 2024
13F
Legal & General Group Plc
13F
Company
0.41%
173,759
$61,309,126 31 Dec 2024
13F
SCHRODER INVESTMENT MANAGEMENT GROUP
13F
Company
0.38%
163,782
$58,574,995 31 Dec 2024
13F
Palo Alto Investors LP
13F
Company
0.36%
155,714
$54,942,128 31 Dec 2024
13F
TD ASSET MANAGEMENT INC
13F
Company
0.35%
150,454
$53,086,189 31 Dec 2024
13F
DEUTSCHE BANK AG\
13F
Company
0.34%
143,629
$50,678,056 31 Dec 2024
13F
Polaris Capital Management, LLC
13F
Company
0.31%
131,850
$46,521,954 31 Dec 2024
13F
Retirement Systems of Alabama
13F
Company
0.3%
129,611
$45,731,945 31 Dec 2024
13F

Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q1 2025

As of 31 Mar 2025, UNITED THERAPEUTICS Corp - Common Stock (UTHR) was held by 661 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 44,441,020 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, WELLINGTON MANAGEMENT GROUP LLP, GEODE CAPITAL MANAGEMENT, LLC, FMR LLC, AQR CAPITAL MANAGEMENT LLC, and LSV ASSET MANAGEMENT. This page lists 665 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 holders
667
Q1 2025 holders
661
Holder diff
-6
Investor Q4 2024 Shares Q1 2025 Shares Share Diff Share Chg % Q4 2024 Value $ Q1 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .